Conventional dendritic cells are more activated in the hyperplastic Thymus of myasthenia gravis patients

2024-10-1

Discordance of reported multiple sclerosis clinical course amongst patients and providers

2024-10-1

Efgartigimod as a fast-acting add-on therapy in manifest and impending myasthenic crisis: A single-center case series

2024-10-1

Age and sex-dependent gut alterations in mice induced by neonatal immune activation with lipopolysaccharide

2024-10-1

Multimodal magnetic resonance longitudinal study on the deep gray matter in multiple sclerosis patients with teriflunomide

2024-9-3

Intravascular lymphoma: A diagnostic challenge for a treatable cause of rapidly progressive dementia

2024-9-1

A ferroptosis-associated prognostic model correlated with immune landscape and radiotherapy response in low-grade gliomas (LGGs)

2024-9-1

Fluorescence-detection size-exclusion chromatography specifically detects autoantibodies targeting the ganglionic acetylcholine receptor in patients with autoimmune autonomic ganglionopathy

2024-9-1

Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis

2024-9-1

Spectrum of Auto-antibodies in NMO and MOG Associated CNS Demyelination- The SANMAD Study

2024-9-1

Macrophage-derived exosomes exacerbate postoperative cognitive dysfunction in mice through inflammation

2024-9-1

Proteomics analysis of immune response-related proteins in Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

2024-9-1

Sexual dimorphism of hypothalamic serotonin release during systemic inflammation: Role of endothelin-1

2024-9-1

Ofatumumab treatment for severe refractory anti-NMDAR encephalitis: A case series

2024-9-1

Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?

2024-9-1

Elevated C1s/C1-INH in serum and plasma of myasthenia gravis patients

2024-9-1

Novel model of multiple sclerosis induced by EBV-like virus generates a unique B cell population

2024-9-1

Editorial Board

2024-9-1

JAK inhibition in down syndrome regression disorder

2024-8-23

Fibrinolysis associated proteins and lipopolysaccharide bioactivity in plasma and cerebrospinal fluid in multiple sclerosis

2024-8-12

IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report

2024-8-8

Probiotics-regulated lithocholic acid suppressed B-cell differentiation in neuromyelitis optica spectrum disorder

2024-8-3

Soluble adhesion molecules: Cognitive worsening biomarkers in primary progressive multiple sclerosis?

2024-8-1

Clinical characteristics, immunological alteration and distinction of MOG-IgG-associated disorders and GFAP-IgG-associated disorders

2024-8-1

Microglial-mediated immune mechanisms in autoimmune uveitis: Elucidating pathogenic pathways and targeted therapeutics

2024-8-1

Targeting VEGF-mediated blood-brain barrier disruption in advanced cerebral leukodystrophy

2024-8-1

Editorial Board

2024-8-1

A retrospective case series of pure spinal multiple sclerosis: Disrupting MS boundaries or evolving spectrum?

2024-8-1

XMEN disease caused by the novel MAGT1 p.(Trp136*) mutation may present with neuropsychiatric symptoms

2024-8-1

Spinocerebellar ataxia masquerading as multiple sclerosis, a case report

2024-8-1

HMGB1/TLR4 axis promotes pyroptosis after ICH by activating the NLRP3 inflammasome

2024-8-1

Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms

2024-8-1

Geraniol (GER) attenuated chronic sleep restriction (CSR)-induced neuroinflammation in adolescent mice

2024-8-1

Long-term cognitive outcomes in Susac syndrome: A case series

2024-8-1

Corrigendum to “Germinal center B cells are dispensable in prion transport and neuroinvasion”. [2007 Dec;192(1–2):113–23. doi: 10.1016/j.jneuroim.2007.09.022. Epub 2007 Oct 26. PMID: 17964667]

2024-8-1

Infections and neurodegenerative diseases: A complex, still enigmatic connection

2024-7-30

Immune-regulating effect of oxytocin and its association with the hypothalamic-pituitary axes

2024-7-27

Co-localization and co-expression of Olfml3 with Iba1 in brain of mice

2024-7-26

Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study

2024-7-24

Severe cerebral amyloid angiopathy related inflammation (CAA-ri) associated with vaccination: Case report and literature review

2024-7-23

A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review

2024-7-23

Authors' response to letter to the editor: Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis

2024-7-18

Tenascin-C in patients with central nervous system infections

2024-7-1

Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study

2024-7-1

Neuroinflammation, neurodegeneration and alteration of spatial memory in BALB/c mice through ampicillin-induced gut dysbiosis; NOS2 and NFL involvement in a microbiota-gut-brain axis model

2024-7-1

Exploring the causal role of immune cells in vascular dementia: A bidirectional Mendelian randomization study

2024-7-1

Electroconvulsive therapy in N-methyl-d-aspartate receptor encephalitis: A retrospective cohort and scoping review of literature

2024-7-1

Toxoplasma gondii infection supports the infiltration of T cells into brain tumors

2024-7-1

Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy

2024-7-1

Anti-contactin-associated protein 1 antibody-positive nodopathy presenting with central nervous system symptoms

2024-7-1